Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.63 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4247638 | 1.00 | NPSR1 (0.63) | NPSR1HCAR2GLO1ALDH1A1TRPA1 | |
| SCHEMBL4247641 | 1.00 | NPSR1 (0.63) | NPSR1HCAR2GLO1ALDH1A1TRPA1 | |
| SCHEMBL1321694 | 0.80 | NPSR1 (0.65) | NPSR1HCAR2GLO1ALDH1A1TRPA1 | |
| SCHEMBL5667523 | 0.80 | NPSR1 (0.65) | NPSR1HCAR2GLO1ALDH1A1TRPA1 | |
| SCHEMBL5612231 | 0.80 | NPSR1 (0.65) | NPSR1HCAR2GLO1ALDH1A1TRPA1 | |
| SCHEMBL8733229 | 0.79 | — | — | |
| SCHEMBL5087405 | 0.79 | — | — | |
| SCHEMBL6002149 | 0.79 | HCAR2 (0.47) | NPSR1HCAR2ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL4246454 | 0.79 | HCAR2 (0.47) | NPSR1HCAR2ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL4246450 | 0.79 | HCAR2 (0.47) | NPSR1HCAR2ALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111840113-B | Antibacterial skin cleaning lotion | 百草堂(湖北)制药有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-112042664-B | Mildew-proof antibacterial agent | 广州古神生物科技有限公司 | 2022-06-10 | — | — | CN | claimed |
| CN-111957266-B | Antibacterial surfactant and antibacterial and bacteriostatic application thereof in daily chemical products | 广州古神生物科技有限公司 | 2022-06-07 | — | — | CN | claimed |
| EP-2295438-B2 | PROCESS FOR PRODUCING HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND, AND CATALYST COMPOSITION FOR THE PRODUCTION OF POLYURETHANE RESIN USING THE HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND | TOSOH CORP (JP) | 2025-03-26 | — | — | EP | disclosed |
| CN-111840113-B | Antibacterial skin cleaning lotion | 百草堂(湖北)制药有限公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-112042664-B | Mildew-proof antibacterial agent | 广州古神生物科技有限公司 | 2022-06-10 | — | — | CN | disclosed |
| CN-111957266-B | Antibacterial surfactant and antibacterial and bacteriostatic application thereof in daily chemical products | 广州古神生物科技有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-105837714-B | The manufacturing method of solid catalyst component for olefin polymerization, the manufacturing method of polymerization of olefines catalyst and olefin polymer | 东邦钛株式会社 | 2018-07-20 | — | — | CN | disclosed |
| CN-104470953-B | Process for producing solid catalyst component for olefin polymerization, catalyst for olefin polymerization, and process for producing olefin polymer | 东邦钛株式会社 | 2017-11-14 | — | — | CN | disclosed |
| US-20160355616-A1 | Polyvinyl Pyrrolidone analog Polymers | LOGIN ROBERT BERNARD (US) | 2016-12-08 | — | — | US | disclosed |
| EP-2105431-A1 | Process for Producing Chromone Compound | Sumitomo Chemical Company, Limited (JP) | 2009-09-30 | — | — | EP | disclosed |
| EP-2105432-A1 | Process for Producing Chromone Compound | Sumitomo Chemical Company, Limited (JP) | 2009-09-30 | — | — | EP | disclosed |
| CN-101203142-A | Aromatic amides and ureas and their uses as sweet and/or delicate flavor modifiers, flavouring agents and taste enhancers | SENOMYX INC (US) | 2008-06-18 | — | — | CN | disclosed |
| EP-1867626-A2 | Process for producing chromone compound | Sumitomo Chemical Company, Limited (JP) | 2007-12-19 | — | — | EP | disclosed |
| US-20060217565-A1 | Process for producing chromone compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-09-28 | — | — | US | disclosed |
| US-7094914-B2 | Process for producing chromone compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-08-22 | — | — | US | disclosed |
| US-20050085664-A1 | Process for producing chromone compound | SUMITOMO CHEMICAL COMPANY, LMITED (JP) | 2005-04-21 | — | — | US | disclosed |
| EP-1479667-A1 | PROCESS FOR PRODUCING CHROMONE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2004-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050085664-A1 | Process for producing chromone compound | ENY2, CDY1; CDY1B, CDYL | NPSR1 937/4885HCAR2 354/4885GLO1 3348/4885 |
| US-20160355616-A1 | Polyvinyl Pyrrolidone analog Polymers | PBRM1, HMBS, BPGM | NPSR1 918/4885HCAR2 1743/4885GLO1 784/4885 |
| US-20060217565-A1 | Process for producing chromone compound | ENY2, CDY1; CDY1B, CDYL | NPSR1 937/4885HCAR2 354/4885GLO1 3348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.